India has overtaken China in the MSCI Emerging Markets Investable Market Index, with a weightage of 22.27 per cent compared to China’s 21.58 per cent. This change is expected to bring around $4.5 billion into Indian equities, reflecting India’s strong macroeconomic fundamentals and robust corporate performance.
Related Posts
Aurobindo Pharma arm CuraTeQ gets positive EMA opinion for biosimilar Zefylti
Aurobindo Pharma’s subsidiary, CuraTeQ Biologics, received a positive CHMP opinion for its filgrastim biosimilar, Zefylti, intended to treat neutropenia and mobilize peripheral progenitor cells. Zefylti […]
How RBI’s gold buying is helping shore up India’s foreign exchange reserves
The Reserve Bank of India has substantially increased its gold reserves, offsetting foreign investment outflows. This aligns with a global trend of central banks accumulating […]